Nicotine patches may help patients with Tourette's syndrome control involuntary movements.

Report on studies of nicotine and other nicotinic agonists on improving performance on attention and memory tasks, as well as on treating Alzheimer's disease, schizophrenia, and attention-deficit/hyperactivity disorder.

Report that a nicotine metabolite may improve memory and protect brain cells from diseases such as Alzheimer's and Parkinson's. The researcher is Dr. Jerry J. Buccafusco, director of the Alzheimer's Research Center at the Medical College of Georgia.

News article in Boston Globe about research indicating that nicotine seems to diminish mental impairment stemming from stress or an underactive thyroid, and may help people with brain disorders ranging from Alzheimer's disease to schizophrenia.

Report by Duke University behavioral pharmacologist Edward Levin that nicotine-like compounds help restore the ability to learn and remember in rats that have brain lesions similar to those found in Alzheimer's disease patients. Reported in Science Daily News.

Nicotine-based therapy for weight control, pain relief, and treatment of neurodegenerative and mental disorders.

Recent research finds cigarettes cause faster mental decline as smokers get older.

50 year research finds cigarettes lower intelligence, increase memory loss, slow reflexes, and impair problem solving ability.

Contrary to suggestions from previous research, this study of over 34,000 subjects found no effect of smoking on senility or Alzheimer's. The previous suggestions that it did came from flawed studies, say the authors.

Recent research finds that tobacco products increase Alzheimer's disease on some populations, but have no effect on other populations.

New studies suggest that cigarettes are a cause of some psychiatric disorders, including common conditions such as depression and anxiety.

Recent research shows that tobacco products may cause anxiety, panic attacks and fear of leaving home.

Report presented at the 8th International Conference on Alzheimer's Disease and Related Disorders, based on research conducted by Sara Debanne, PhD, at Case Western Reserve University.

Largest and most recent study indicates that smokers are twice as likely to develop Alzheimer's disease and other forms of dementia.

Research evidence is the apparent relaxing effect of smoking only reflects the reversal of the tension and irritability that develop during nicotine depletion.

Article summarizes increasing evidence from larger research studies that tobacco products cause anxiety, depression, phobias, and alcohol and drug dependence.

A study led by Paul Newhouse, M.D., at the University of Vermont will examine nicotine's effect on mild cognitive impairment.